Published: April 4, 2024
Objective: The aim of our study was to perform a retrospective analysis the volume cervical screening tests, number patients treated with an excision method, and incidence invasive non-invasive during pandemic pre-pandemic period 24 months. Results: There statistically significant age difference between two periods, both by average group. mean 32 years before pan-demic 35 (p-value >0.05). majority presenting for investigations were in 30-39-year-old group (31.95%, respectively; 34.2% = 0.003). biggest patient loss ratio identified 50–59 years: 14,53% 9,1% period. In period, from rural areas presented clinical trial lower rate 39.52% (83 patients) vs. 60.47% (127 urban areas. A higher percentage experiencing cervicorrhagia as manifestation prepandemic increase more severe lesions has statistical significance 8% newly diagnosed compared Conclusion: addressability COVID not affected drastic way study. We encountered decrease appointments residence. study, we found reason consultation lesion degree, on pap smear biopsy.
Language: Английский
Citations
1
Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14
Published: May 29, 2024
Background The COVID-19 pandemic led to a national lockdown and the interruption of all cancer preventive services, including cervical screening. We aimed assess impact on opportunistic screening participation, abnormal cytology (ASCUS+) prevalence interval in 2020 2021 within Public Health System Catalonia, Spain. Methods Individual data HPV testing women aged 25–65 from 2014 were retrieved Information for Primary Care Services (SISAP). Time-series regression models used estimate expected participation 2021. was determined by comparing observed values (ratios). Additionally, changes trends between assessed fitting Piecewise linear model. Results Cervical decreased 38.8% 2.2% 2021, respectively, with most significant (-96.1%) occurring April 2020. Among older women, lower, it took longer recover. Abnormal 1.4 times higher than variations age (range=1.1–1.5). From June onwards, trend significantly changed an increase 0.59 3.57 months per year, resulting median time 48 December Conclusions During pandemic, fewer have participated screening, has increased, is more prolonged before. potential lifetime risk implications highlight need organized HPV-based
Language: Английский
Citations
1
Infectious Diseases Now, Journal Year: 2024, Volume and Issue: 54(7), P. 104978 - 104978
Published: Sept. 20, 2024
Language: Английский
Citations
0
Journal of Obstetrics and Gynaecology Research, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 9, 2024
This study investigated the impact of coronavirus disease 2019 (COVID-19) on clinical characteristics and interregional movement patients with uterine cervical cancer.
Language: Английский
Citations
0
Published: Nov. 9, 2023
Citations
1
In Vivo, Journal Year: 2024, Volume and Issue: 38(2), P. 734 - 740
Published: Jan. 1, 2024
Background/Aim: The global impact of the COVID-19 pandemic resulted in disruptions to healthcare systems throughout world. numbers cytology examinations, human papillomavirus (HPV) tests, and women referred for colposcopy decreased many countries. There have been no reports on cervical cancer screening Germany. This study aimed describe changes colposcopies, HPV histological results during compared pre-pandemic years order evaluate screening. Patients Methods: histologic were analyzed retrospectively period January 2018 December 2022. 2 before (2018 2019) with 3 (2020-2022). Results: In total, 6,518 colposcopies performed 5,579 women. high-risk (hrHPV) tests increased years. number biopsies per year taken was stable (range=450-554). relative intraepithelial neoplasia (CIN) III/HSIL findings stable, while cancers identified slightly from 15 (6.6%) 22 (7.4%) Conclusion: Increases examined observed 2021 2022 pandemic, comparison preceding These also led increases figures cytology, hrHPV, histology, operations. onset occurred same as a newly organized program started might therefore be due system.
Language: Английский
Citations
0
Medicina, Journal Year: 2024, Volume and Issue: 60(6), P. 909 - 909
Published: May 30, 2024
Background and Objectives: Our aim was to perform a retrospective analysis of the volume cervical screening tests, number patients treated with an excision method, incidence invasive non-invasive during pandemic pre-pandemic period 24 months. Materials Methods: The study compared 404 who underwent cone biopsy for cancer. examined patients’ specimens based on histopathological characteristics categorized lesions pap smear. Results: There statistically significant age difference between two periods. mean 32 years before 35 (p-value > 0.05). biggest patient loss ratio identified by group in 50–59-year group, 14.53% 9.1% period. In period, from rural areas presented clinical trial lower rate 39.52% (83 patients) vs. 60.47% (127 urban areas. A higher percentage experiencing cervicorrhagia as manifestation increase more severe had statistical significance 8% newly diagnosed Conclusions: addressability COVID not affected drastic way our study. We encountered decrease appointments 50–59 residence. study, we found bleeding reason consultation lesion degree, both smear biopsy.
Language: Английский
Citations
0
Revista Mexicana de Medicina Familiar, Journal Year: 2024, Volume and Issue: 11(2)
Published: July 16, 2024
RESUMEN: Antecedentes: En 2020, la Organización Mundial de Salud declaró COVID-19 como pandemia, por lo que se suspendieron los programas tamizaje, afectando detección oportuna del cáncer mama en todo el mundo y generando un aumento casos posterior a pandemia.Objetivo: Determinar proporción BI-RADS 4 5 mastografías realizadas las restricciones comparadas con año 2019.Material métodos: Estudio observacional, transversal comparativo pacientes o tras 2019 una unidad medicina familiar.Resultados: De total 945 mastografías, realizaron 2 415 3 530 2022.En 2019, 69 fueron > (2.85%) 2022 aumentaron 175 (4.95%) (p = 0.001).Este incremento fue proporcional para todos grupos etarios < 0.045).Conclusiones: Hubo 73% más clasificadas comparación previo ella.
Citations
0
Health Services Insights, Journal Year: 2024, Volume and Issue: 17
Published: Jan. 1, 2024
A qualitative exploration was conducted to analyse the reasons behind low utilisation of cervical cancer screening services in Gwanda district, Zimbabwe, focusing on impact COVID-19 pandemic. The study involved 5 focus group discussions with 36 women, utilising maximum variation sampling explore effects coverage. Additionally, in-depth interviews were 25 health-care providers from primary health facilities and provincial hospital offering services. results suggest a decline progress programme due disruptions caused by which subsequently reduced women’s access treatment It anticipated that restoring confidence adherence would require time post-pandemic. Moreover, findings highlighted potential progression undetected precursor lesions advanced stages during non-screening periods, may increase future morbidity mortality. underscore importance integrating messaging within broader communication strategies emphasise significance interventions for overall well-being. This recommends adoption more efficient methods, such as Human-Papillomavirus self-sampling mitigate services, thereby guiding policymakers towards implementing best approaches.
Language: Английский
Citations
0
Cancers, Journal Year: 2024, Volume and Issue: 16(20), P. 3495 - 3495
Published: Oct. 15, 2024
Background: This study aims to evaluate patients with locally advanced cervical cancer who underwent definitive radiochemotherapy, including brachytherapy, at the University Hospital of Muenster (UKM), focusing on target volume coverage, oncologic outcome parameters, and organs risk (OAR) toxicities. Results are compared Gyn GEC-ESTRO (GGE) recommendations. Methods: Of a cohort 48 patients, treated between 2013 2023, physical radiation treatment planning application CT MRI follow-up data was analyzed. Target structures, comprising high-risk clinical (HR-CTV), intermediate-risk (IR-CTV), Point A, corresponding EQD2(α/β=10) doses were determined. Endpoints included local tumor control, overall survival (OS), recurrence-free (RFS), progression-free (PFS). Total OAR (D2cc) EQD2(α/β=3) correlated adverse events defined by CTCAE v5.0 LENT-SOMA criteria. Results: Median 58.0 months (95% CI [27.6, 88.4]). FIGO stage I present in 7 (15%) II 13 (27%), III 28 (58%) patients. A total 38 (79%) showed complete remission 3 after treatment. The 5-year event-free rate 67.4% [49.3, 80.3]) for OS, 77.0% [56.7, 88.6]) RFS 68.1% [49.7, 80.9]) PFS. Incomplete stages led worse outcomes. Meeting GGE recommendations increased chances could decrease an event occurring PFS, RFS. Compliance lowered toxicity occurring. Conclusions: MRI-based definition brachytherapy may improve patients’ Time-to-event endpoints consistent comparable studies, adherence current ESGO/ESTRO/ESP guidelines is endorsed.
Language: Английский
Citations
0